172 related articles for article (PubMed ID: 18952719)
1. Darbepoetin-alpha prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure.
Rastogi S; Imai M; Sharov VG; Mishra S; Sabbah HN
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2475-82. PubMed ID: 18952719
[TBL] [Abstract][Full Text] [Related]
2. Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.
Rastogi S; Sharov VG; Mishra S; Gupta RC; Blackburn B; Belardinelli L; Stanley WC; Sabbah HN
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2149-55. PubMed ID: 18820026
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure.
Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Goldstein S; Sabbah HN
J Am Coll Cardiol; 2000 Jan; 35(1):222-9. PubMed ID: 10636284
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.
Suzuki G; Morita H; Mishima T; Sharov VG; Todor A; Tanhehco EJ; Rudolph AE; McMahon EG; Goldstein S; Sabbah HN
Circulation; 2002 Dec; 106(23):2967-72. PubMed ID: 12460880
[TBL] [Abstract][Full Text] [Related]
5. Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure.
Zacà V; Rastogi S; Imai M; Wang M; Sharov VG; Jiang A; Goldstein S; Sabbah HN
J Am Coll Cardiol; 2007 Aug; 50(6):551-7. PubMed ID: 17678740
[TBL] [Abstract][Full Text] [Related]
6. Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
Morita H; Khanal S; Rastogi S; Suzuki G; Imai M; Todor A; Sharov VG; Goldstein S; O'Neill TP; Sabbah HN
Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2522-7. PubMed ID: 16428338
[TBL] [Abstract][Full Text] [Related]
7. Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure.
Suzuki G; Khanal S; Rastogi S; Morita H; Mishima T; Anagnostopoulos PV; Nass O; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2007 Feb; 21(1):29-36. PubMed ID: 17294127
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure.
Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2002 May; 16(3):209-14. PubMed ID: 12374898
[TBL] [Abstract][Full Text] [Related]
9. Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Kourea K; Panou F; Farmakis D; Paraskevaidis I; Ikonomidis I; Filippatos G; Kremastinos DT
Am Heart J; 2008 Apr; 155(4):751.e1-7. PubMed ID: 18371487
[TBL] [Abstract][Full Text] [Related]
10. Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure.
Tanimura M; Sharov VG; Shimoyama H; Mishima T; Levine TB; Goldstein S; Sabbah HN
Am J Physiol; 1999 Apr; 276(4):H1385-92. PubMed ID: 10199866
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
[TBL] [Abstract][Full Text] [Related]
12. Acute ventricular reduction with the acorn cardiac support device: effect on progressive left ventricular dysfunction and dilation in dogs with chronic heart failure.
Chaudhry PA; Anagnostopouls PV; Mishima T; Suzuki G; Nair H; Morita H; Sharov VG; Alferness C; Sabbah HN
J Card Surg; 2001; 16(2):118-26. PubMed ID: 11766829
[TBL] [Abstract][Full Text] [Related]
13. Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure.
Suzuki G; Mishima T; Tanhehco EJ; Sharov VG; Todor A; Rostogi S; Gupta RC; Chaudhry PA; Anagnostopoulos PV; Nass O; Goldstein S; Sabbah HN
Br J Pharmacol; 2003 Jan; 138(2):301-9. PubMed ID: 12540520
[TBL] [Abstract][Full Text] [Related]
14. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
Sabbah HN; Shimoyama H; Kono T; Gupta RC; Sharov VG; Scicli G; Levine TB; Goldstein S
Circulation; 1994 Jun; 89(6):2852-9. PubMed ID: 8205701
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure.
Sabbah HN; Wang M; Gupta RC; Rastogi S; Ilsar I; Sabbah MS; Kohli S; Helgerson S; Lee RJ
JACC Heart Fail; 2013 Jun; 1(3):252-8. PubMed ID: 23998003
[TBL] [Abstract][Full Text] [Related]
17. Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure.
Sabbah HN; Gupta RC; Kohli S; Wang M; Rastogi S; Zhang K; Zimmermann K; Diedrichs N; Albrecht-Küpper BE
Circ Heart Fail; 2013 May; 6(3):563-71. PubMed ID: 23564604
[TBL] [Abstract][Full Text] [Related]
18. Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure.
Zacà V; Rastogi S; Mishra S; Wang M; Sharov VG; Gupta RC; Goldstein S; Sabbah HN
Cardiology; 2009; 112(4):294-302. PubMed ID: 18832825
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
Morita H; Suzuki G; Mishima T; Chaudhry PA; Anagnostopoulos PV; Tanhehco EJ; Sharov VG; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2002 Sep; 16(5):443-9. PubMed ID: 12652114
[TBL] [Abstract][Full Text] [Related]
20. Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs.
Rastogi S; Guerrero M; Wang M; Ilsar I; Sabbah MS; Gupta RC; Sabbah HN
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1501-9. PubMed ID: 21217070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
